A carregar...
Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse
BACKGROUND: Up to 75% of people with serious mental illness (SMI) such as schizophrenia and bipolar disorder have co‐occurring substance use disorders (dual diagnosis). Dual diagnosis can have an adverse effect on treatment and prognosis of SMI. OBJECTIVES: To evaluate the effects of risperidone com...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491096/ https://ncbi.nlm.nih.gov/pubmed/29355909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011057.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|